All Stories

  1. Association of Combined Sero-Positivity to Helicobacter pylori and Streptococcus gallolyticus with Risk of Colorectal Cancer
  2. Cryo-EM reveals species-specific components within the Helicobacter pylori Cag type IV secretion system core complex
  3. The Helicobacter pylori Cag Type IV Secretion System
  4. Temporal Control of the Helicobacter pylori Cag Type IV Secretion System in a Mongolian Gerbil Model of Gastric Carcinogenesis
  5. Lipoprotein Processing and Sorting in Helicobacter pylori
  6. Functional Properties of Helicobacter pylori VacA Toxin m1 and m2 Variants
  7. Bacterial Energetic Requirements for Helicobacter pylori Cag Type IV Secretion System-Dependent Alterations in Gastric Epithelial Cells
  8. Structure of a molecular machine in a bacterium that contributes to gastric cancer
  9. Effect of environmental salt concentration on the Helicobacter pylori exoproteome
  10. In Situ Molecular Architecture of the Helicobacter pylori Cag Type IV Secretion System
  11. Cryo-EM Analysis Reveals Structural Basis of Helicobacter pylori VacA Toxin Oligomerization
  12. Transmaternal Helicobacter pylori exposure reduces allergic airway inflammation in offspring through regulatory T cells
  13. Helicobacter pylori VacA Targets Myeloid Cells in the Gastric Lamina Propria To Promote Peripherally Induced Regulatory T-Cell Differentiation and Persistent Infection
  14. Intracellular Degradation of Helicobacter pylori VacA Toxin as a Determinant of Gastric Epithelial Cell Viability
  15. Serologic Response to Helicobacter pylori Proteins Associated With Risk of Colorectal Cancer Among Diverse Populations in the United States
  16. Role of a Stem-Loop Structure in Helicobacter pylori cagA Transcript Stability
  17. Carcinogenic Helicobacter pylori Strains Selectively Dysregulate the In Vivo Gastric Proteome, Which May Be Associated with Stomach Cancer Progression
  18. Antibody Responses to Streptococcus Gallolyticus Subspecies Gallolyticus Proteins in a Large Prospective Colorectal Cancer Cohort Consortium
  19. Helicobacter pylori genetic diversification in the Mongolian gerbil model
  20. Determinants of Raft Partitioning of the Helicobacter pylori Pore-Forming Toxin VacA
  21. High-Salt Conditions Alter Transcription of Helicobacter pylori Genes Encoding Outer Membrane Proteins
  22. Genetic signatures for Helicobacter pylori strains of West African origin
  23. Helicobacter pylori Vacuolating Toxin and Gastric Cancer
  24. Pan-genomic analyses identify key Helicobacter pylori pathogenic loci modified by carcinogenic host microenvironments
  25. Helicobacter pylori and its secreted immunomodulator VacA protect against anaphylaxis in experimental models of food allergy
  26. Magnetic Extraction of Acinetobacter baumannii Using Colistin-Functionalized γ-Fe2O3/Au Core/Shell Composite Nanoclusters
  27. Oxidative Phosphorylation System in Gastric Carcinomas and Gastritis
  28. Dynamic Computational Model of Symptomatic Bacteremia to Inform Bacterial Separation Treatment Requirements
  29. Dietary Composition Influences Incidence of Helicobacter pylori-Induced Iron Deficiency Anemia and Gastric Ulceration
  30. Epithelial Coculture and l-Lactate Promote Growth of Helicobacter cinaedi under H2-Free Aerobic Conditions
  31. Colistin-Functionalized Nanoparticles for the Rapid Capture of Acinetobacter baumannii
  32. Structural organization of membrane-inserted hexamers formed byHelicobacter pyloriVacA toxin
  33. A Nonoligomerizing Mutant Form of Helicobacter pylori VacA Allows Structural Analysis of the p33 Domain
  34. An Overview of Helicobacter pylori VacA Toxin Biology
  35. Peptidomimetic Small Molecules Disrupt Type IV Secretion System Activity in Diverse Bacterial Pathogens
  36. Helicobacter pylori and stomach cancer
  37. Type IV secretion system in Helicobacter pylori
  38. Growth phase-dependent composition of the Helicobacter pylori exoproteome
  39. Supporting data for analysis of the Helicobacter pylori exoproteome
  40. Helicobacter pylori AdaptationIn Vivoin Response to a High-Salt Diet
  41. Alteration of theHelicobacter pylorimembrane proteome in response to changes in environmental salt concentration
  42. Regulation ofHelicobacter pyloriVirulence Within the Context of Iron Deficiency
  43. The Host Protein Calprotectin Modulates the Helicobacter pylori cag Type IV Secretion System via Zinc Sequestration
  44. Effective treatment of allergic airway inflammation with Helicobacter pylori immunomodulators requires BATF3-dependent dendritic cells and IL-10
  45. Genes Required for Assembly of Pili Associated with the Helicobacter pylori cag Type IV Secretion System
  46. Helicobacter pylori outer membrane proteins
  47. Vacuolating Cytotoxin
  48. Human and Helicobacter pylori coevolution shapes the risk of gastric disease
  49. Control of gene expression in Helicobacter pylori using the Tet repressor
  50. Diet, microbial virulence, andHelicobacter pylori-induced gastric cancer
  51. Role of Connexin 43 in Helicobacter pylori VacA-Induced Cell Death
  52. Genome Sequences of Three hpAfrica2 Strains of Helicobacter pylori
  53. Impaired Autophagy, Defective T Cell Homeostasis, and a Wasting Syndrome in Mice with a T Cell-Specific Deletion of Vps34
  54. Flagellar Localization of a Helicobacter pylori Autotransporter Protein
  55. High Dietary Salt Intake Exacerbates Helicobacter pylori-Induced Gastric Carcinogenesis
  56. Functional Plasticity in the Type IV Secretion System of Helicobacter pylori
  57. Structure of the vacuolating toxin VacA from Helicobacter pylori
  58. Genetic analysis of Helicobacter pylori strains from East Asia
  59. Downregulated Th17 responses are associated with reduced gastritis in Helicobacter pylori–infected children
  60. Structural Characterization of the Helicobacter Pylori VacA Toxin by Single Particle Em and X-Ray Crystallography
  61. Iron deficiency accelerates Helicobacter pylori–induced carcinogenesis in rodents and humans
  62. Analysis ofHelicobacter pylori cagAPromoter Elements Required for Salt-Induced Upregulation of CagA Expression
  63. The Intermediate Region of Helicobacter pylori VacA Is a Determinant of Toxin Potency in a Jurkat T Cell Assay
  64. Role ofHelicobacter pyloriCagL in modulating gastrin expression
  65. Non‐invasive Genotyping of Helicobacter pylori cagA, vacA, and hopQ from Asymptomatic Children
  66. J-Western Forms of Helicobacter pylori cagA Constitute a Distinct Phylogenetic Group with a Widespread Geographic Distribution
  67. Alterations in Helicobacter pylori Triggered by Contact with Gastric Epithelial Cells
  68. An RGD Helper Sequence in CagL of Helicobacter pylori Assists in Interactions with Integrins and Injection of CagA
  69. Helicobacter pylori type IV secretion system
  70. Analysis of cagA in Helicobacter pylori Strains from Colombian Populations with Contrasting Gastric Cancer Risk Reveals a Biomarker for Disease Severity
  71. β-Catenin and p120 Mediate PPARδ-Dependent Proliferation Induced by Helicobacter pylori in Human and Rodent Epithelia
  72. Colon-specific delivery of a probiotic-derived soluble protein ameliorates intestinal inflammation in mice through an EGFR-dependent mechanism
  73. Helicobacter pylori VacA Induces Programmed Necrosis in Gastric Epithelial Cells
  74. Phylogeographic origin of Helicobacter pylori is a determinant of gastric cancer risk
  75. Molecular Evolution of the Helicobacter pylori Vacuolating Toxin Gene vacA
  76. Reconstitution of Helicobacter pylori VacA toxin activity from p33 and p55 domains
  77. Analysis of Protein Expression Regulated by the Helicobacter pylori ArsRS Two-Component Signal Transduction System
  78. Analysis of a β-helical region in the p55 domain of Helicobacter pylori vacuolating toxin
  79. In Helicobacter pylori auto-inducer-2, but not LuxS/MccAB catalysed reverse transsulphuration, regulates motility through modulation of flagellar gene transcription
  80. Regulation of Gastric B Cell Recruitment Is Dependent on IL-17 Receptor A Signaling in a Model of Chronic Bacterial Infection
  81. Helicobacter pylori in Health and Disease
  82. Epidermal Growth Factor Receptor Activation Protects Gastric Epithelial Cells From Helicobacter pylori-Induced Apoptosis
  83. Genome sequence analysis of Helicobacter pylori strains associated with gastric ulceration and gastric cancer
  84. Structural Analysis of the DNA-binding Domain of the Helicobacter pylori Response Regulator ArsR
  85. Helicobacter pyloriHopQ outer membrane protein attenuates bacterial adherence to gastric epithelial cells
  86. Helicobacter pyloriand mitogen-activated protein kinases mediate activator protein-1 (AP-1) subcomponent protein expression and DNA-binding activity in gastric epithelial cells
  87. Helicobacter pylori VacA Disrupts Apical Membrane-Cytoskeletal Interactions in Gastric Parietal Cells
  88. Helicobacter pylori VacA Subdomain Required for Intracellular Toxin Activity and Assembly of Functional Oligomeric Complexes
  89. β2 Integrin Mediates Entry of a Bacterial Toxin into T Lymphocytes
  90. Crystal structure of the Helicobacter pylori vacuolating toxin p55 domain
  91. Host response to Helicobacter pylori infection before initiation of the adaptive immune response
  92. Helicobacter pylori Vacuolating Cytotoxin Inhibits Activation-Induced Proliferation of Human T and B Lymphocyte Subsets
  93. l-Arginine Availability Regulates Inducible Nitric Oxide Synthase-Dependent Host Defense against Helicobacter pylori
  94. Regulation of Helicobacter pylori cagA Expression in Response to Salt
  95. Soluble Proteins Produced by Probiotic Bacteria Regulate Intestinal Epithelial Cell Survival and Growth
  96. Serological Assays for Identification of Human Gastric Colonization by Helicobacter pylori Strains Expressing VacA m1 or m2
  97. Functional Analysis of Neutralizing Antibodies against Clostridium perfringens Epsilon-Toxin
  98. Role ofHelicobacter pyloriOuter Membrane Proteins in Gastroduodenal Disease
  99. Resistance of Primary Murine CD4+ T Cells to Helicobacter pylori Vacuolating Cytotoxin
  100. Helicobacter pylori Persistence: an Overview of Interactions between H. pylori and Host Immune Defenses
  101. Helicobacter pylori VacA Toxin Inhibits Human Immunodeficiency Virus Infection of Primary Human T Cells
  102. Random Mutagenesis of Helicobacter pylori vacA To Identify Amino Acids Essential for Vacuolating Cytotoxic Activity
  103. Quantitative Effect of luxS Gene Inactivation on the Fitness of Helicobacter pylori
  104. Protein-Protein Interactions among Helicobacter pylori Cag Proteins
  105. Multiple Chromosomal Loci for the babA Gene in Helicobacter pylori
  106. Requirement of Histidine Kinases HP0165 and HP1364 for Acid Resistance in Helicobacter pylori
  107. Mapping of a Domain Required for Protein-Protein Interactions and Inhibitory Activity of a Helicobacter pylori Dominant-Negative VacA Mutant Protein
  108. Helicobacter pylori vacuolating toxin
  109. Mimicry of a Host Anion Channel by a Helicobacter pylori Pore-Forming Toxin
  110. Analysis ofhopQalleles in East Asian and Western strains ofHelicobacter pylori
  111. The Oxysterol-binding Protein Homologue ORP1L Interacts with Rab7 and Alters Functional Properties of Late Endocytic Compartments
  112. High resolution structural analysis of Helicobacter pylori VacA toxin oligomers by cryo-negative staining electron microscopy
  113. Genomic Comparison of cag Pathogenicity Island (PAI)-Positive and -Negative Helicobacter pylori Strains: Identification of Novel Markers for cag PAI-Positive Strains
  114. Functional Properties of the p33 and p55 Domains of the Helicobacter pylori Vacuolating Cytotoxin
  115. Helicobacter pylori VacA, a paradigm for toxin multifunctionality
  116. Growth Phase Regulation of flaA Expression in Helicobacter pylori Is luxS Dependent
  117. Targeting of Helicobacter pylori vacuolating toxin to lipid raft membrane domains analysed by atomic force microscopy
  118. Heterogeneity among Helicobacter pylori Strains in Expression of the Outer Membrane Protein BabA
  119. Inhibition of primary human T cell proliferation byHelicobacter pylorivacuolating toxin (VacA) is independent of VacA effects on IL-2 secretion
  120. Clustering and Redistribution of Late Endocytic Compartments in Response to Helicobacter pylori Vacuolating Toxin
  121. Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells
  122. Interactions between p-33 and p-55 Domains of the Helicobacter pylori Vacuolating Cytotoxin (VacA)
  123. Cellular Vacuolation and Mitochondrial Cytochrome c Release Are Independent Outcomes of Helicobacter pylori Vacuolating Cytotoxin Activity That Are Each Dependent on Membrane Channel Formation
  124. Promoter analysis of Helicobacter pylori genes with enhanced expression at low pH
  125. Expression of Helicobacter pylori Vacuolating Toxin in Escherichia coli
  126. Effects ofHelicobacter pylorion intracellular Ca2+signaling in normal human gastric mucous epithelial cells
  127. Essential Role of a GXXXG Motif for Membrane Channel Formation by Helicobacter pylori Vacuolating Toxin
  128. Recovery from lactacidosis-induced glial cell swelling with the aid of exogenous anion channels
  129. Two Different Families of hopQ Alleles in Helicobacter pylori
  130. Global analysis of Helicobacter pylori gene expression in human gastric mucosa
  131. PIKfyve Kinase and SKD1 AAA ATPase Define Distinct Endocytic Compartments. ONLY PIKfyve EXPRESSION INHIBITS THE CELL-VACUOLATING ACTIVITY OF HELICOBACTER PYLORI VacA TOXIN
  132. Genome-Wide Transcriptional Profiling in a Histidine Kinase Mutant of Helicobacter pylori Identifies Members of a Regulon
  133. Association of Helicobacter pylori Vacuolating Toxin (VacA) with Lipid Rafts
  134. Multiple Oligomeric States of the Helicobacter pylori Vacuolating Toxin Demonstrated by Cryo-electron Microscopy
  135. A 12-Amino-Acid Segment, Present in Type s2 but Not Type s1 Helicobacter pylori VacA Proteins, Abolishes Cytotoxin Activity and Alters Membrane Channel Formation
  136. In search of the Helicobacter pylori VacA mechanism of action
  137. Antigenic Diversity among Helicobacter pyloriVacuolating Toxins
  138. Helicobacter pylori genotypes, host factors, and gastric mucosal histopathology in peptic ulcer disease
  139. Amino-Terminal Hydrophobic Region ofHelicobacter pylori Vacuolating Cytotoxin (VacA) Mediates Transmembrane Protein Dimerization
  140. Carboxy-Terminal Proteolytic Processing ofHelicobacter pylori Vacuolating Toxin
  141. Acid activation of Helicobacter pylori vacuolating cytotoxin (VacA) results in toxin internalization by eukaryotic cells
  142. Intercellular Communication in Helicobacter pylori: luxS Is Essential for the Production of an Extracellular Signaling Molecule
  143. Cell Vacuolation Induced by the VacA Cytotoxin of Helicobacter pylori Is Regulated by the Rac1 GTPase
  144. A Dominant Negative Mutant of Helicobacter pyloriVacuolating Toxin (VacA) Inhibits VacA-induced Cell Vacuolation
  145. Vacuolating Cytotoxin ( vacA ) Alleles of Helicobacter pylori Comprise Two Geographically Widespread Types, m1 and m2, and Have Evolved Through Limited Recombination
  146. Helicobacter pylori Vacuolating Cytotoxin (VacA) Disorganizes the Cytoskeletal Architecture of Gastric Epithelial Cells
  147. Helicobacter pylori factors associated with disease
  148. Release ofHelicobacter pylori vacuolating cytotoxin by both a specific secretion pathway and budding of outer membrane vesicles. Uptake of released toxin and vesicles by gastric epithelium
  149. VacA fromHelicobacter pylori: a hexameric chloride channel
  150. The vacuolating toxin from Helicobacter pylori forms hexameric pores in lipid bilayers at low pH
  151. Acid-induced expression of an LPS-associated gene inHelicobacter pylori
  152. The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity
  153. Helicobacter pylori upregulates expression of epidermal growth factor-related peptides, but inhibits their proliferative effect in MKN 28 gastric mucosal cells.
  154. An intracellular target for Helicobacter pylori vacuolating toxin
  155. Acid-induced Dissociation of VacA, theHelicobacter pyloriVacuolating Cytotoxin, Reveals Its Pattern of Assembly
  156. Clinical and pathological importance of heterogeneity in vacA, the vacuolating cytotoxin gene of Helicobacter pylori
  157. High-level genetic diversity in the vapD chromosomal region of Helicobacter pylori.
  158. Effects of Helicobacter pylori vacuolating cytotoxin on primary cultures of human gastric epithelial cells.
  159. Density of Helicobacter pylori Infection In Vivo as Assessed by Quantitative Culture and Histology
  160. The gastrin-histamine sequence
  161. The vacuolating cytotoxin of Helicobacter pylori
  162. Helicobacter pylori and gastric acid: Biological and therapeutic implications
  163. Mosaicism in Vacuolating Cytotoxin Alleles of Helicobacter pylori
  164. Analysis of Genetic Diversity in Cytotoxin-Producing and Non-Cytotoxin Producing Helicobacter pylori Strains
  165. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism
  166. The proton pump inhibitor omeprazole inhibits acid survival of Helicobacter pylori by a urease-independent mechanism
  167. Helicobacter pylori infection in japanese patients with adenocarcinoma of the stomach
  168. Potentiation of Helicobacter pylori Vacuolating Toxin Activity by Nicotine and Other Weak Bases
  169. Characterization of Hela cell vacuoles induced by Helicobacter pylori broth culture supernatant
  170. Serum neutralizing antibody response to the vacuolating cytotoxin of Helicobacter pylori.
  171. Helicobacter Pylori and Gastroduodenal Disease
  172. Evaluation of cytotoxic activity in fecal filtrates from patients with or enteritis
  173. Yersinia Enterocolitica
  174. The Pathobiology of Campylobacter Infections in Humans
  175. Pseudomonas paucimobilis Empyema After Cardiac Transplantation